Contract award · 4 Aug 2026

Ru-106 Eye Applicators

NHS Greater Glasgow and Clyde awarded “Ru-106 Eye Applicators” to Eckert & Ziegler BEBIG GmbH for £200k on 4 Aug 2026. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
NHS Greater Glasgow and Clyde · Body governed by public law
Value
£200,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Radiotherapy devices and supplies (CPV 33151000)
Region
Scotland
Timeline
  1. Contract date4 Aug 2026
  2. Published10 Sep 2026Published 37 days after the contract date

Description

Ru-106 eye applicators are ophthalmic brachytherapy plaques used primarily for treating uveal melanoma, retinoblastoma, and other ocular tumors. They consist of a thin film of Ru-106 beta-emitting isotope, encapsulated in pure silver sheets, with a total thickness of only 1 mm, making them easy to handle and position on the eye surface. The beta radiation has a limited range, allowing high doses to tumors up to 5 mm in thickness while sparing sensitive structures like the optic disc and fovea. Additional information: Approximately six (6) Ru-106 Eye Applicators required to be purchased and returned per year, this contract will cover a 36 month period

About the supplier

More from NHS Greater Glasgow and Clyde

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview